Smoking cessation among inner-city African Americans unsing the nicotine transdermal patch
OBJECTIVE: To determine the efficacy of the transdermal nicotine patch for smoking cessation in inner-city African Americans.
DESIGN: Double-blind, placebo-controlled, randomized trial.
SETTING: Outpatient in an inner-city hospital.
PATIENTS AND PARTICIPANTS: A computer-generated random numbers table with a block size set at 20 was used to randomize 410 patients to one of two study arms.
INTERVENTIONS: The transdermal nicotine patch for 10 weeks as an adjunct to brief counseling.
MEASUREMENTS AND MAIN RESULTS: Of the 410 patients randomized, mean age was 48 years, 65% were female, 41% had less than a high school education, 51% had an annual household income of less than $8,000, and the average number of cigarettes smoked per day was 20. Quit rates at 10 weeks were 21.5% (44/205) with the nicotine patch, and 13.7% (28/205) with the placebo patch (p=.03). At 6 months, quit rates were 17.1% (35/205) with the nicotine patch, and 11.7% (24/205) with the placebo patch (p=.08). After adjusting for baseline differences in age and educational attainment, differences remained significant at 10 weeks (p=.04), but were not significant at 6 months (p=.14). Compliance rates for return visits were 83%, 78%, 55%, and 52%, at 1, 2, 6, and 10 weeks, respectively.
CONCLUSIONS: The nicotine patch significantly improves short-term quit rates in inner-city African Americans who are interested in trying to quit smoking. Efforts should be made to reach underserved populations through smoking cessation programs, and to assist in maintaining abstinence.
Key wordssmoking cessation African Americans innercity patients nicotine patch
Unable to display preview. Download preview PDF.
- 2.Centers for Disease Control. Cigarette smoking among adults—United States, 1993. MMWR. 1994;43:925–30.Google Scholar
- 3.Center for Disease Control. African Americans and smoking. Centers for Disease Control—At A Glance.Google Scholar
- 4.Givino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J. Epidemiology of tobacco use and dependence. Epidemiol Rev. 1995;17:48–65.Google Scholar
- 6.Ahluwalia JS, McNagny SE. Smoking prevalence and desire to quit in inner-city African-American walk-in clinic patients. Clin Res. 1993;41:752A.Google Scholar
- 8.Office on Smoking and Health. Adult Use of Tobacco. Washington, DC: U.S. Dept. of Health and Human Services, Public Health Service; 1989: PHS publication 90-2004.Google Scholar
- 9.U.S. Dept. of Health and Human Services. Reducing the Health Consequences of Smoking: 25 years of Progress. A Report of the Surgeon General. Washington, DC: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1989. DHHS publication (CDC) 89-8411.Google Scholar
- 10.U.S. Dept. Health and Human Services. The Health Benefits of Smoking Cessation. U.S. Dept. Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990. DHHS publication (CDC) 90–8416.Google Scholar
- 11.Martin R, Commings SR, Coates TJ. Ethnicity and smoking: differences in white, black, Hispanic and Asian. AM J Prev Med. 1990;6:194–9.Google Scholar
- 13.Centers for Disease Control. Smoking cessation during previous year among adults—United States, 1990 and 1991. MMWR. 1993;42:504–7.Google Scholar
- 19.Fiore MC, Bailey WC, Cohen SJ, et al. Smoking Cessation: Iformation for Specialists. Clinical Practice Guideline. Quick Reference Guide for Smoking Cessation Specialists, No. 18. Rockvill, Md: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Centers for Disease Control and Prevention; 1996.Google Scholar
- 21.Gorsline J, Gupta SK, Dye D, Rolf CN. Nicotine dose relationship for Nicoderm (nicotine transdermal system) at steady state. Pharmacol Res. 1991;10 (suppl):S299.Google Scholar
- 22.Robinson RG, Orleans CT, James DA, Sutton CD. Pathways to Freedom: Winning the Fight Against Tobacco. Philadelphia, Pa: Fox Chase Center; 1992.Google Scholar
- 23.Marion Merrill Dow Inc. The 6-2-2 Committed Quitter’s Program: Nicoderm (Nicotine Transdermal System). Kansas City, Mo: Marion Merrill Dow Inc.; 1993.Google Scholar
- 28.Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley and Sons; 1989.Google Scholar
- 35.Robinson RG, Pertschuk JD, Sutton C. Smoking and African Americans. In: Samuels SE, Smith MD, eds. Improving the Health of the Poor—Strategies for Prevention. Menlo Park, Calif: The Henry J. Kaiser Family Foundation; 1992.Google Scholar
- 37.National Cancer Institute. Cancer Prevention Awareness Survey Wave II: Management Summary. Bethesda, Md: Office of Cancer Communications, National Cancer Institute, National Institutes of Health; 1987.Google Scholar
- 43.Glynn TJ, Boyd GM, Gruman JC. Self-Guided Strategies for Smoking Cessation: A Program Planner’s Guide. Bethesda, Md: Smoking and Tobacco Control Program, National Center Institute, USDHHS; 1990.Google Scholar
- 44.U.S. Dept. of Health and Human Services. The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. Washington, DC: U.S. Dept. of Health and Human Services; 1988. DHHS publication (CDC) 88–8406.Google Scholar
- 47.U.S. Dept. of Health and Human Services. Healthy People 2000: Midcourse Review and 1995 Revisions. Washington, DC: Government Printing Office; 1995.Google Scholar